Covid Vaccine Covovax
- All
- News
- Videos
-
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
China Needs "Good Covid Booster" Like Covovax, Says Adar Poonawalla
China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Exclusive: "Telling China To Take Our Booster," Adar Poonawalla Tells NDTV
The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
Covovax Vaccine Now Available For 12-17 Age Group At Private Centres
Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday.
-
Covovax First Indian Covid Vaccine To Be Sold In Europe: Adar Poonawalla
Serum Institute's Adar Poonawalla said Covovax is the first vaccine made in India to be sold in Europe.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
Influential US Congress Members Urge Vaccine Collaboration With India
Members of America's influential Congressional Hispanic Caucus have urged US President Joe Biden to champion vaccine collaboration with India to bring an end to the COVID-19 pandemic.
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
Centre Allows Export Of 7 Crore Covovax Doses To Three Foreign Countries
The Indian government has permitted the export of seven crore doses of the Covid vaccine Covovax produced by the Serum Institute of India to Netherlands, Australia, and New Zealand, official sources said today.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
China Needs "Good Covid Booster" Like Covovax, Says Adar Poonawalla
China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Exclusive: "Telling China To Take Our Booster," Adar Poonawalla Tells NDTV
The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
Covovax Vaccine Now Available For 12-17 Age Group At Private Centres
Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday.
-
Covovax First Indian Covid Vaccine To Be Sold In Europe: Adar Poonawalla
Serum Institute's Adar Poonawalla said Covovax is the first vaccine made in India to be sold in Europe.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
Influential US Congress Members Urge Vaccine Collaboration With India
Members of America's influential Congressional Hispanic Caucus have urged US President Joe Biden to champion vaccine collaboration with India to bring an end to the COVID-19 pandemic.
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
Centre Allows Export Of 7 Crore Covovax Doses To Three Foreign Countries
The Indian government has permitted the export of seven crore doses of the Covid vaccine Covovax produced by the Serum Institute of India to Netherlands, Australia, and New Zealand, official sources said today.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
